EBS:NYSE
Emergent Biosolutions Inc
US$ 6.91
0.00%
(0.00) Siku 1
US$ 6.80
arrow_downward
-1.59% (-0.11)bedtimeBaada ya saa
Imefungwa: 14 Okt, 16:00:03 GMT -4 · USD
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya EBS...
Fungua
US$ 6.87
Juu
US$ 7.07
Chini
US$ 6.81
Mtaji wa soko
354.30M
Wastani wa kiasi cha mauzo
1.14M
Kiasi cha mauzo ya hisa
elfu 762.10
Juu kwa wiki 52
US$ 14.06
Chini kwa wiki 52
US$ 4.36
EPS
-US$ 3.51
Beta
2.28
Hisa za wawekezaji
51.27M
Idadi ya wafanyakazi
900
Fungua
US$ 6.87
Juu
US$ 7.07
Chini
US$ 6.81
Mtaji wa soko
354.30M
Wastani wa kiasi cha mauzo
1.14M
Kiasi cha mauzo ya hisa
elfu 762.10
Juu kwa wiki 52
US$ 14.06
Chini kwa wiki 52
US$ 4.36
EPS
-US$ 3.51
Beta
2.28
Hisa za wawekezaji
51.27M
Idadi ya wafanyakazi
900
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
Business Wire
·
dakika 12 zilizopita
Iambic Announces Pricing of Initial Public Offering
RealMoney Pro
·
dakika 8 zilizopita
Hotter Inflation and AI Weakness End the S&P 500’s Run Without a 1% Drop
Honolulu Star-Advertiser
·
dakika 41 zilizopita
Nasdaq suffers biggest daily drop since July as inflation heats up
Bloomberg.com
·
saa 2 zilizopita
S&P 500 Ends Longest Streak of Calm Since 2020 as AI Trade Sinks
Wasifu
Emergent BioSolutions Inc. is an American multinational specialty biopharmaceutical company headquartered in Gaithersburg, Maryland. It develops vaccines and antibody therapeutics for infectious diseases and opioid overdoses, and it provides medical devices for biodefense purposes.
Among the company's products are the controversial BioThrax, the only anthrax vaccine licensed by the U.S. Food and Drug Administration and Narcan for the emergency treatment of opioid overdose. The company also manufactures pharmaceuticals for infectious diseases like cholera and typhoid.
During the COVID-19 pandemic, Emergent BioSolutions also produced Johnson & Johnson/Janssen and Oxford–AstraZeneca vaccines at one of its plants; however, this was marked by contamination and other production issues, and millions of doses of vaccine had to be discarded. Wikipedia
Kuhusu Emergent Biosolutions Inc
Afisa Mkuu Mtendaji (CEO)Robert G. Kramer Sr. | Joseph C. Papa
Wafanyakazi900
Lilianzishwa5 Sep 1998
Makao makuuRockville, Maryland, Marekani
Sekta-
Tovutiemergentbiosolutions.com